AstraZeneca share price falls and ends day 1% down after UK regulator said under-30s should not take the jab
AstraZeneca‘s share price has slumped by one per cent after UK health chiefs said Britons under 30 should not take its vaccine.
The British-Swedish pharmaceutical firm, based in Cambridge, was trading at 7.110 points on Tuesday morning.
But it dipped down to 7.107 at 8am before a sharp rise back up to 7.139 within 20 minutes.
It continued to fluctuate throughout the morning and early afternoon – straying from 7.160 at 9.47am to a lunchtime low of 7.121.
Yet the stocks took their biggest hit just after 3.30pm when it was announced the jabs should not be used on people under 30.
The share price nosedived back down to 7.110 points at 3.40pm before staying steady at 7.111 when the markets closed at 4.30pm.